ChiCTR2600122228 版本V1.0 版本创建时间2026/04/10 11:12:40 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600122228 

最近更新日期:

Date of Last Refreshed on:

2026-04-10 11:12:33 

注册时间:

Date of Registration:

2026-04-10 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

消化内镜手术患者侧卧位经鼻气管插管的有效性和安全性:一项前瞻性随机对照研究

Public title:

The efficacy and safety of nasotracheal Intubation in the lateral position for patients undergoing digestive endoscopy: a prospective randomized controlled trial

注册题目简写:

English Acronym:

研究课题的正式科学名称:

消化内镜手术患者侧卧位经鼻气管插管的有效性和安全性:一项前瞻性随机对照研究

Scientific title:

The efficacy and safety of nasotracheal Intubation in the lateral position for patients undergoing digestive endoscopy: a prospective randomized controlled trial

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

孙晨雨 

研究负责人:

孙晨雨 

Applicant:

Chenyu Sun 

Study leader:

Chenyu Sun 

申请注册联系人电话:

Applicant telephone:

+86 188 7521 2346

研究负责人电话:

Study leader's
telephone:

+86 188 7521 2346

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1164337146@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1164337146@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

山东省滨州市滨城区黄河二路661号

研究负责人通讯地址:

山东省滨州市滨城区黄河二路661号

Applicant address:

No. 661, Huanghe 2nd Road, Bincheng District, Binzhou City, Shandong Province

Study leader's address:

No. 661, Huanghe 2nd Road, Bincheng District, Binzhou City, Shandong Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

滨州医学院附属医院

Applicant's institution:

Affiliated Hospital of Binzhou Medical University

研究负责人所在单位:

滨州医学院附属医院

Affiliation of the Leader:

Affiliated Hospital of Binzhou Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2025]伦审字(KYLL-220)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

滨州医学院附属医院科研伦理委员会

Name of the ethic committee:

Institutional Review Board, Affiliated Hospital of Binzhou Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2025-12-22 00:00:00

伦理委员会联系人:

蔡国伟

Contact Name of the ethic committee:

Guowei Cai

伦理委员会联系地址:

山东省滨州市滨城区黄河二路661号

Contact Address of the ethic committee:

No. 661, Huanghe 2nd Road, Bincheng District, Binzhou City, Shandong Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 157 6216 7051

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

滨州医学院附属医院

Primary sponsor:

Affiliated Hospital of Binzhou Medical University

研究实施负责(组长)单位地址:

山东省滨州市滨城区黄河二路661号

Primary sponsor's address:

No. 661, Huanghe 2nd Road, Bincheng District, Binzhou City, Shandong Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山东

市(区县):

Country:

China

Province:

Shandong

City:

单位(医院):

滨州医学院附属医院

具体地址:

山东省滨州市滨城区黄河二路661号

Institution
hospital:

Affiliated Hospital of Binzhou Medical University

Address:

No. 661, Huanghe 2nd Road, Bincheng District, Binzhou City, Shandong Province

经费或物资来源:

自筹

Source(s) of funding:

Self-funding

研究疾病:

消化内镜手术  

Target disease:

Gastrointestinal Endoscopy

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究拟通过设计随机对照试验(RCT),科学评估在消化内镜手术中,侧卧位经鼻气管插管在插管时间及首次插管成功率等方面与仰卧位经鼻气管插管的差异。同时观察与仰卧位经鼻气管插管后调整体位相比,直接侧卧位经鼻气管插管是否在患者血流动力学波动及术后并发症发生等方面优于前者,并进一步阐明其可能发生机制。  

Objectives of Study:

This study aims to conduct a randomized controlled trial (RCT) to scientifically evaluate the differences in intubation time and the first-time intubation success rate between lateral decubitus position nasal tracheal intubation and supine position nasal tracheal intubation during digestive endoscopic surgery. At the same time, it will observe whether direct lateral decubitus position nasal tracheal intubation is superior to the latter in terms of hemodynamic fluctuations and postoperative complications in patients, and further clarify the possible mechanism.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.择期行上消化道内镜手术患者 2.年龄18~80岁 3.ASA分级I-III级 4.BMI为18-30Kg/m^2

Inclusion criteria

1. Patients scheduled for upper gastrointestinal endoscopic surgery 2. Age range: 18 - 80 years old 3. ASA classification: I - III 4. BMI: 18 - 30 kg/m^2

排除标准:

1.鼻腔肿物或严重鼻中隔偏曲 2.既往鼻咽部手术患者 3.凝血功能障碍 4.困难气道风险(甲颏距离<6cm,张口度<3.5cm,Mallampati分级>=III级)

Exclusion criteria:

1. Nasal cavity tumor or severe deviation of the nasal septum 2. Patients who have undergone previous nasopharyngeal surgery 3. Coagulation dysfunction 4. Risk of difficult airway (mandibular-mental distance < 6cm, mouth opening < 3.5cm, Mallampati grade >= III)

研究实施时间:

Study execute time:

From 2026-04-01 00:00:00 To 2026-11-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-04-10 00:00:00 To 2026-11-01 00:00:00

干预措施:

Interventions:

组别:

侧卧位经鼻气管插管组(L组)

样本量:

90

Group:

Lateral position nasotracheal intubation group

Sample size:

干预措施:

L组患者入室后自行调整为左侧卧位,麻醉诱导及插管过程中均保持左侧卧位,头部置于支撑枕上,使头颈部矢状轴与床面平行并保持颈部伸展。

干预措施代码:

Intervention:

L-group patients adjusted themselves to the left lateral position after entering the operating room, maintained this position throughout anesthesia induction and intubation, with the head placed on a support pillow to keep the sagittal axis of the head and neck parallel to the bed surface while maintaining neck extension.

Intervention code:

组别:

仰卧位经鼻气管插管组(S组)

样本量:

90

Group:

Supine nasotracheal intubation group

Sample size:

干预措施:

S组患者入室后取仰卧位,在枕部下方放置支撑枕,并根据需要调整至“嗅花”体位直至建立人工气道;气管插管成功后,将患者调整为转为左侧卧位

干预措施代码:

Intervention:

For patients in Group S, after entering the room, they were placed in the supine position with a support pillow underneath the occiput, and the position was adjusted to the "sniffing" position as needed until the artificial airway was established. Upon successful endotracheal intubation, the patient was repositioned to the left lateral position.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山东省 

市(区县):

 

Country:

China

Province:

Shandong

City:

单位(医院):

滨州医学院附属医院 

单位级别:

三甲 

Institution
hospital:

Affiliated Hospital of Binzhou Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

插管时间方面(定义导管尖端进入鼻孔到导管进入气管的持续时长为插管时间)

指标类型:

主要指标

Outcome:

In terms of intubation time (defined as the duration from the tip of the tube entering the nostril to the tube entering the trachea).

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

鼻腔通过时间(定义为导管尖端进入鼻孔到通过鼻后孔时间)

指标类型:

次要指标

Outcome:

Nasal passage time (defined as the duration from the tip of the tube entering the nostril to its passage through the posterior nasal aperture/choana).

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

插管尝试次数

指标类型:

次要指标

Outcome:

Number of intubation attempts

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

首次插管成功率

指标类型:

次要指标

Outcome:

First attempt success rate

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

助手辅助动作(包括协助暴露声门及协助气管插管)及插管辅助工具使用情况(如使用Magill持管钳或纤支镜等工具)

指标类型:

次要指标

Outcome:

Assistant's maneuvers (including assistance in exposing the glottis and assisting with endotracheal intubation) and the use of intubation assistive devices (such as Magill forceps or fibreoptic bronchoscope, etc.).

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

采用改良经鼻气管插管困难量表对插管条件进行量化评估

指标类型:

次要指标

Outcome:

The intubation conditions were quantitatively assessed using the Modified Nasotracheal Intubation Difficulty Scale.

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

采用C-L分级评估喉部显露情况

指标类型:

次要指标

Outcome:

The laryngeal view was assessed using the Cormack-Lehane (C-L) grade.

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

插管前(T1)、插管即刻(T2)、插管后1min(T3)、翻身后(T4)的MAP及HR,以及插管过程中最低SpO2

指标类型:

次要指标

Outcome:

MAP and HR before intubation (T1), immediately after intubation (T2), 1 min after intubation (T3), and after position change (T4), as well as the lowest SpO? during intubation.

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

观察拔管后鼻出血、声音嘶哑及咽喉痛的发生情况

指标类型:

次要指标

Outcome:

Observe the occurrence of epistaxis, hoarseness, and sore throat after extubation.

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

医生及护士的满意度

指标类型:

次要指标

Outcome:

Satisfaction of doctors and nurses

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由不参与试验的人员使用随机数字表法进行随机

Randomization Procedure (please state who generates the random number sequence and by what method):

Using the random number table method, personnel who were not involved in the experiment randomly selected the participants.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF;EDC

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF;EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-04-10 11:12:33